Quick Answer
Mineralys Therapeutics, Inc. reported Shares Outstanding of 81.54 million shares for fiscal year 2025.
Mineralys Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 81.54M | +63.7% |
| 2024 | 49.82M | +21.1% |
| 2023 | 41.13M | +540.8% |
| 2022 | 6.42M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 78.97M | +58.7% | +20.2% |
| June 30, 2025 | 65.73M | +32.2% | +1.3% |
| March 31, 2025 | 64.88M | +30.7% | +30.2% |
| December 31, 2024 | 49.82M | +21.1% | +0.1% |
| September 30, 2024 | 49.76M | +21.0% | +0.1% |
| June 30, 2024 | 49.71M | +21.7% | +0.2% |
| March 31, 2024 | 49.63M | +21.5% | +20.7% |
| December 31, 2023 | 41.13M | +540.8% | +0.1% |
- Mineralys Therapeutics, Inc. showed an increase of +63.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2022–2025 period, Mineralys Therapeutics, Inc.’s shares outstanding has grown by 1170.2% (from 6.42 million shares to 81.54 million shares).
- The most recent figure is from Mineralys Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: